. Author manuscript; available in PMC: 2020 May 1.

Published in final edited form as: Ophthalmol Retina. 2019 Jan 31;3(5):436–443. doi: 10.1016/j.oret.2019.01.016

Table 2.

Indications of fluorescein angiography among the treated and untreated cohorts between 1^st December 2013 and 31^st July 2018

Anti-VEGF cohort	Untreated cohort
• Persistent avascular retina at >60 weeks post-menstrual age in 16 (80.0%) • Recurrence of stage 3 ROP or plus disease in 4 (20.0%)	• Persistent avascular retina at >60 weeks post-menstrual age in 5 (62.5%) • Evaluation of a chorioretinal lesion in 1(12.5 %) • Evaluation of an optic nerve lesion in 1 (12.5%) • Spontaneous vitreous hemorrhage in 1 (12.5%)